TY - JOUR
T1 - An unbalanced synaptic transmission
T2 - Cause or consequence of the amyloid oligomers neurotoxicity?
AU - Sciaccaluga, Miriam
AU - Megaro, Alfredo
AU - Bellomo, Giovanni
AU - Ruffolo, Gabriele
AU - Romoli, Michele
AU - Palma, Eleonora
AU - Costa, Cinzia
N1 - Funding Information:
G.B. was supported by the JPND bPRIDE (blood Proteins for early Discrimi-nation of dEmentias) project. The project leading this result has received funding under the call JPco-fuND-2: ?Multinational research projects on Personalised Medicine for Neurodegenerative Diseases? (CUP number J99C18000210005). G.R. was supported by BE-FOR-ERC program (Sapienza University) and Italian Ministry of Health ?Ricerca corrente?.
Funding Information:
Acknowledgments: G.B. was supported by the JPND bPRIDE (blood Proteins for early Discrimination of dEmentias) project. The project leading this result has received funding under the call JPco-fuND-2: “Multinational research projects on Personalised Medicine for Neurodegenerative Diseases” (CUP number J99C18000210005). G.R. was supported by BE-FOR-ERC program (Sapienza University) and Italian Ministry of Health “Ricerca corrente”.
Publisher Copyright:
© 2021 by the authorsLicensee MDPI, Basel, Switzerland.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Amyloid-β (Aβ) 1-40 and 1-42 peptides are key mediators of synaptic and cognitive dysfunction in Alzheimer’s disease (AD). Whereas in AD, Aβ is found to act as a pro-epileptogenic factor even before plaque formation, amyloid pathology has been detected among patients with epilepsy with increased risk of developing AD. Among Aβ aggregated species, soluble oligomers are suggested to be responsible for most of Aβ’s toxic effects. Aβ oligomers exert extracellular and intracellular toxicity through different mechanisms, including interaction with membrane receptors and the formation of ion-permeable channels in cellular membranes. These damages, linked to an unbalance between excitatory and inhibitory neurotransmission, often result in neuronal hy-perexcitability and neural circuit dysfunction, which in turn increase Aβ deposition and facilitate neurodegeneration, resulting in an Aβ-driven vicious loop. In this review, we summarize the most representative literature on the effects that oligomeric Aβ induces on synaptic dysfunction and network disorganization.
AB - Amyloid-β (Aβ) 1-40 and 1-42 peptides are key mediators of synaptic and cognitive dysfunction in Alzheimer’s disease (AD). Whereas in AD, Aβ is found to act as a pro-epileptogenic factor even before plaque formation, amyloid pathology has been detected among patients with epilepsy with increased risk of developing AD. Among Aβ aggregated species, soluble oligomers are suggested to be responsible for most of Aβ’s toxic effects. Aβ oligomers exert extracellular and intracellular toxicity through different mechanisms, including interaction with membrane receptors and the formation of ion-permeable channels in cellular membranes. These damages, linked to an unbalance between excitatory and inhibitory neurotransmission, often result in neuronal hy-perexcitability and neural circuit dysfunction, which in turn increase Aβ deposition and facilitate neurodegeneration, resulting in an Aβ-driven vicious loop. In this review, we summarize the most representative literature on the effects that oligomeric Aβ induces on synaptic dysfunction and network disorganization.
KW - Aβ oligomers
KW - Calcium homeostasis
KW - Excitatory/inhibitory unbalance
KW - Hyperexcitability
KW - Network dysfunction
KW - Neurotoxicity
KW - Synaptic plasticity
UR - http://www.scopus.com/inward/record.url?scp=85106956034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106956034&partnerID=8YFLogxK
U2 - 10.3390/ijms22115991
DO - 10.3390/ijms22115991
M3 - Review article
C2 - 34206089
AN - SCOPUS:85106956034
SN - 1661-6596
VL - 22
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 11
M1 - 5991
ER -